Microbiology Studies of Acute Head and Neck Infections
NCT05874908 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2025-02-28
Summary
Acute head and neck infections cause significant pain and discomfort for patients and impact on their quality of life. Effective antibiotic and surgical treatments have been developed for these infections but they are still able to develop into life-threatening diseases such as meningitis and sepsis. The direct cause of acute head and neck infections is often unknown but it has been suggested that they are due to a disturbance of the normal bacterial growing in the mouth or are from dental origin.
The most common microorganisms identified from these infections in published studies are a group of bacteria known as viridans group streptococci (VGS). There are over 30 individual species of bacteria in the viridans group and VGS are difficult to identify to the level of a single species because of their variability. There is a lack of species identification within the hospital setting and this project aims to gain a deeper understanding of the microorganisms causing acute head and neck infections, focusing on identification of individual species of VGS bacteria.
The investigators will analyse bacterial DNA to determine which species have been identified and will also look at patient data and clinical outcomes (eg. length of hospital stay) to determine if the species causing the infection has any effect on patients.
Conditions
- Head and Neck Infection
Sponsors & Collaborators
-
Northampton General Hospital NHS Trust
collaborator OTHER -
The University of Northampton
lead OTHER
Principal Investigators
-
Alexandra Woodacre, PhD, BSc · University of Northampton
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-03-03
- Primary Completion
- 2026-04-19
- Completion
- 2026-04-19
Countries
- United Kingdom
Study Locations
More Related Trials
-
Microbiology, Antimicrobial Resistance and Outcomes of Neonatal Sepsis in China
NCT05089760 ·Status: UNKNOWN
-
The Effectiveness of Antimicrobial Breathing System on the Presence of Multidrug-resistant Organisms
NCT04927806 ·Status: COMPLETED ·Phase: NA
-
Antistaphylococcal Betalactam and Emergence of Resistance
NCT05939479 ·Status: COMPLETED
-
Cellulitis Optimal Antibiotic Treatment
NCT05584007 ·Status: RECRUITING ·Phase: PHASE3
-
Population Pharmacokinetic-pharmacodynamic (PK-PD) Study of 9 Broad-Spectrum Anti-infective Agents in the Cerebro Spinal Fluid (CSF) of Brain Injured Patients With an External Ventricular Drainage (EVD).
NCT03481569 ·Status: COMPLETED ·Phase: PHASE1
-
Antibiotic Outbreak, Risk Factors for Never Event, Prediction of Inappropriate Use
NCT03489330 ·Status: COMPLETED
-
Clinical Outcomes of Hypervirulent Carbapenem-resistant Klebsiella Pneumoniae Infection
NCT06190548 ·Status: COMPLETED
-
Risk Factors for Linezolid Resistance in Staphylococcus Aureus
NCT00519025 ·Status: COMPLETED
-
NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria
NCT05017766 ·Status: RECRUITING
-
Validation of Biomarkers Performance to Reduce Antibiotics overUse in newBorns With Suspected Clinical Signs of InfectionS
NCT06058819 ·Status: RECRUITING
-
Shortened Antibiotic Treatment of 5 Days in Gram-negative Bacteremia
NCT04291768 ·Status: RECRUITING ·Phase: PHASE4
-
Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China
NCT03245632 ·Status: UNKNOWN
-
Cefazolin Versus Antistaphylococcal Penicillins for Methicillin Susceptible Staphylococcus Aureus Bacteremia
NCT07186894 ·Status: ACTIVE_NOT_RECRUITING
-
Diagnostic Performance of Plasma Procalcitonin for the Detection of Blood Cultures Contaminations
NCT04573894 ·Status: COMPLETED
-
Study on Cefotaxime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
NCT01426191 ·Status: COMPLETED
-
Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin
NCT01561469 ·Status: COMPLETED
-
Detection of Clindamycin Resistance Antibiotic Genes Among Staphylococcus Isolates by Using Real Time PCR
NCT04933019 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Quinolone Resistance in Bloodstream Isolates of Escherichia Coli
NCT00449735 ·Status: COMPLETED
-
Gram Negative Bacteremia, Risk Factors for Failure of Therapy
NCT00177957 ·Status: COMPLETED
-
Clinical Performance and Reproducibility of the Accelerate PhenoTest™ Blood Culture (BC) Kit With New Antibiotic Wave I Updates
NCT04295915 ·Status: COMPLETED
-
Analysis on the Infection Risk, Prognosis, and Drug Sensitivity of Klebsiella Pneumoniae.
NCT04337840 ·Status: UNKNOWN
-
A Complicated Skin and Soft-tissue Infection Patient Registry
NCT00737269 ·Status: COMPLETED
-
Human Microbiome and Healthcare Associated Infections - Nursing Home Dwelling Older Veterans
NCT04218799 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of New CLSI Guidelines on Antibiotic Susceptability Pattern
NCT01352377 ·Status: UNKNOWN
-
A Multicentre Pilot Study of Midline Catheter's Tip at a Different Position in Antimicrobial Therapy
NCT04601597 ·Status: COMPLETED ·Phase: NA